The 1 Month Relative Strength measures a stock's price change over the last month relative to the price change of a market index. It shows the relative outperformance or underperformance of the stock in that timeframe.
Research indicates that relative strength is a negative signal in the near-term but generally a positive indicator in the medium (6-24 months).
A study by Hancock found that a momentum-based strategy outperformed a broad universe of U.S. stocks by nearly 4% per year from 1927-2009.
Research has shown that momentum is particularly beneficial when combined with a value style because the two are negatively correlated. Moskowitz and Grinblatt conclude that "A value-momentum combination mitigates the extreme negative return episodes a value investor will face (e.g. the tech boom of the late 1990s and early 2000 or a dismal year like 2008) "However, momentum-based strategies have been shown to suffer badly during times of extreme market volatility such as the 2008/09 crisis.
Ticker | Name | Rel Strength | StockRank™ |
---|---|---|---|
LON:GENI | Genincode | 127% | 6 |
LON:XLM | XLMedia | 93.1% | 88 |
LON:ZOO | Zoo Digital | 62.0% | 46 |
LON:ONC | Oncimmune Holdings | 59.7% | 11 |
LON:CHLL | Chill Brands | 59.1% | 0 |